Moneycontrol PRO
you are here: HomeNewsAstrazeneca
astrazeneca
Jump to
  • AstraZeneca Standalone March 2022 Net Sales at Rs 231.96 crore, up 10.32% Y-o-Y May 27, 2022 04:12 PM IST

    AstraZeneca Standalone March 2022 Net Sales at Rs 231.96 crore, up 10.32% Y-o-Y

  • AstraZeneca's COVID jab Vaxzevria wins EU approval as booster May 23, 2022 02:30 PM IST

    AstraZeneca's COVID jab Vaxzevria wins EU approval as booster

    "Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA COVID-19 vaccine."

  • COVID vaccine maker AstraZeneca sees profit slump Apr 29, 2022 01:36 PM IST

    COVID vaccine maker AstraZeneca sees profit slump

    Profit after tax slumped to $386 million (366 million euros), AstraZeneca said in a statement.

  • World's biggest vaccine maker Serum halts production with 200 million doses spare Apr 23, 2022 09:03 AM IST

    World's biggest vaccine maker Serum halts production with 200 million doses spare

    The Serum Institute has produced more than one billion doses of Covishield -- its version of the AstraZeneca jab -- and is a major supplier to the Covax global inoculation programme for poorer countries.

  • Europe begins reviewing application for AstraZeneca COVID drug Mar 16, 2022 01:10 PM IST

    Europe begins reviewing application for AstraZeneca COVID drug

    Infections from COVID-19 are still rising in parts of the world including Europe.

  • COVID vaccine maker AstraZeneca says 2021 profit dives Feb 10, 2022 02:49 PM IST

    COVID vaccine maker AstraZeneca says 2021 profit dives

    Profit after tax slumped to just $112 million (98 million euros) compared with $3.2 billion in 2020, the pharmaceutical company said in a statement.

  • AstraZeneca Standalone December 2021 Net Sales at Rs 200.53 crore, up 0.14% Y-o-Y Feb 09, 2022 01:22 PM IST

    AstraZeneca Standalone December 2021 Net Sales at Rs 200.53 crore, up 0.14% Y-o-Y

  • AstraZeneca China summoned over suspected fraud Jan 30, 2022 07:52 AM IST

    AstraZeneca China summoned over suspected fraud

    The regulator of the state medical insurance fund said authorities ordered the arrest of all suspects, but did not give details of the suspected violations or the size of funds involved.

  • AstraZeneca says early trial data indicates third dose helps against Omicron Jan 13, 2022 03:37 PM IST

    AstraZeneca says early trial data indicates third dose helps against Omicron

    The increased response, also against the Delta variant, was seen in a blood analysis of people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding that it would submit this data to regulators worldwide given the urgent need for boosters.

  • What is marketing authorisation that Covishield has applied for? Jan 03, 2022 01:52 PM IST

    What is marketing authorisation that Covishield has applied for?

  • AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study Dec 23, 2021 01:19 PM IST

    AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study

    The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.

  • AstraZeneca Covid vaccine protection wanes after three months: Lancet study Dec 21, 2021 05:24 PM IST

    AstraZeneca Covid vaccine protection wanes after three months: Lancet study

    The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with AstraZeneca, known as Covishield in India.

  • USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZeneca Dec 17, 2021 03:36 PM IST

    USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZeneca

    The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.

  • Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations Dec 15, 2021 11:53 AM IST

    Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations

    The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.

  • Trigger of rare blood clots linked with AstraZeneca Covid vaccine found Dec 02, 2021 08:04 PM IST

    Trigger of rare blood clots linked with AstraZeneca Covid vaccine found

    An international team of researchers investigated vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis with thrombocytopenia syndrome (TTS), a life-threatening condition seen in a very small number of people after receiving the adenovirus vaccines.

  • AstraZeneca says it will start profiting from its COVID-19 vaccine Nov 13, 2021 02:57 PM IST

    AstraZeneca says it will start profiting from its COVID-19 vaccine

    To a far greater extent than the vaccines from Pfizer-BioNTech and Moderna, AstraZeneca’s vaccine has been the workhorse of the effort to vaccinate poorer countries, many of which are facing severe vaccine shortages. About 1.1 billion AstraZeneca doses had reached low- and lower-middle income countries as of around the end of October

  • AstraZeneca Standalone September 2021 Net Sales at Rs 197.71 crore, down 5.62% Y-o-Y Nov 11, 2021 10:00 AM IST

    AstraZeneca Standalone September 2021 Net Sales at Rs 197.71 crore, down 5.62% Y-o-Y

  • Pfizer, AstraZeneca COVID vaccines generate more antibodies than natural infection: Study Nov 08, 2021 06:19 PM IST

    Pfizer, AstraZeneca COVID vaccines generate more antibodies than natural infection: Study

    A team led by researchers at the University of Montreal in Canada found that these antibodies were also effective against the Delta variant.

  • AstraZeneca sets up clinical data insights division in India Oct 20, 2021 02:43 PM IST

    AstraZeneca sets up clinical data insights division in India

    The Bengaluru-based clinical data and insights (CDI) division is a critical advancement to support a growing global portfolio and build on internal data expertise, the drug firm said in a statement.

  • WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Mansukh Mandaviya Oct 20, 2021 11:41 AM IST

    WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Mansukh Mandaviya

    Health Minister Mansukh Mandaviya had also tweeted that he had a detailed interaction with the WHO chief, accompanied by other senior officials of the global health agency on various issues related to health, including pandemic management and WHO reforms.

  • AstraZeneca joins hands with RGCI to treat leukaemia patients Oct 19, 2021 02:01 PM IST

    AstraZeneca joins hands with RGCI to treat leukaemia patients

    As part of the programme, the drug maker aims to help identify and support CLL reference laboratories (CRLs) in strategic locations across India and connect peripheral hospitals with them.

  • Valneva jumps on positive results for COVID-19 vaccine candidate Oct 18, 2021 03:47 PM IST

    Valneva jumps on positive results for COVID-19 vaccine candidate

    Valneva is among a handful of vaccine developers testing their vaccines against one already approved by a regulator, rather than giving volunteers a placebo as shots become more available.

  • AstraZeneca seeks US authorisation of drug to prevent COVID-19 Oct 05, 2021 02:13 PM IST

    AstraZeneca seeks US authorisation of drug to prevent COVID-19

    The company has included data from a late-stage trial of more than 5,000 participants that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.

  • India likely to allow smaller gap between two doses of Covishield sold privately: Report Sep 22, 2021 12:15 PM IST

    India likely to allow smaller gap between two doses of Covishield sold privately: Report

    Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine four weeks after the first, down from between 12 and 16 weeks currently, sources said.

  • SII on track to deliver 200 million doses of Covishield per month: Adar Poonawalla Sep 20, 2021 05:51 PM IST

    SII on track to deliver 200 million doses of Covishield per month: Adar Poonawalla

    The SII CEO's statement comes amid the row over the UK tightening quarantine rules for vaccinated Indians. As per the UK government's order, fully vaccinated persons arriving from a number of countries, including India, would be treated as "unvaccinated" and will have to undergo a mandatory 10-day quarantine.

Sections
ISO 27001 - BSI Assurance Mark